MSB 2.17% $1.13 mesoblast limited

For the Number Crunches

  1. 4,640 Posts.
    lightbulb Created with Sketch. 696
    Interested to hear from the value gurus please.

    Amgen plans to buy Horizon Therapeutics for about $28 billion in cash, bringing on board two blockbuster drugs to ease the hit the biotech giant faces from biosimilar competition.

    https://endpts["DOT"]com/amgen-to-buy-horizon-for-28b-in-the-years-biggest-pharma-takeover/

    a) Does a deal like this offer any general value guidance IF MSB can deliver on it's lead programs?

    b) Does this signal the big pharma sector is slipping into deal mode?
    Last edited by Moreforme: 13/12/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.